Objective: To evaluate the effect of nebivolol on microalbuminuria (MA) in hypertensive
patients with or without type 2 diabetes mellitus. Materials and Methods: This was an open …

Increases in the cardiovascular risk marker microalbuminuria are attenuated by blood
pressure reduction using blockers of the renin-angiotensin system. Such changes in …

A total of 26 non-insulin-dependent diabetic patients were enrolled for a clinical study of the
effect of buflomedil on microalbuminuria. None of the subjects had hypertension or …

Background and Objectives: Hypertension is a widely prevalent con-dition of elevated blood
pressure (BP) and is the leading risk factor for the development of cardiovascular disease …

Objectives To address whether nondihydropyridine calcium-channel blocker added-on
angiotensin-converting-enzyme inhibitor therapy ameliorates albuminuria and …

Patients with mild to moderate essential hypertension (n= 1570) were enrolled in a large,
multicentre, randomised, open‐label study designed to evaluate the safety and efficacy of …

Diabetic nephropathy is the most frequent cause of chronic renal failure. The onset of
microalbuminuria in patients with diabetes mellitus, which seems to be related to blood …

BACKGROUND: Type 2 diabetes mellitus (T2DM) with microalbuminuria (MA) is associated
with increased risk of cardiovascular events (CVE) that may be attenuated by angiotensin …

Background: Effective blood pressure (BP)-lowering therapy is regarded as the most
important intervention in diabetes mellitus. Nebivolol is commonly used for the treatment of …

Background—Elevated urine albumin excretion (UAER) is a modifiable risk factor for renal
and cardiovascular disease in type 2 diabetes. Blockade of the renin-angiotensin system …